ZyVersa Therapeutics Inc (ZVSA) concluded trading on Wednesday at a closing price of $0.31, with 11.66 million shares of worth about $3.61 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -76.59% during that period and on July 16, 2025 the price saw a loss of about -43.30%. Currently the company’s common shares owned by public are about 4.87M shares, out of which, 4.86M shares are available for trading.
Stock saw a price change of -51.36% in past 5 days and over the past one month there was a price change of -52.27%. Year-to-date (YTD), ZVSA shares are showing a performance of -93.65% which decreased to -70.63% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $0.47 but also hit the highest price of $5.22 during that period. The average intraday trading volume for ZyVersa Therapeutics Inc shares is 5.51 million. The stock is currently trading -51.14% below its 20-day simple moving average (SMA20), while that difference is down -49.29% for SMA50 and it goes to -72.07% lower than SMA200.
ZyVersa Therapeutics Inc (NASDAQ: ZVSA) currently have 4.87M outstanding shares and institutions hold larger chunk of about 7.28% of that.
The stock has a current market capitalization of $1.52M and its 3Y-monthly beta is at 0.82. It has posted earnings per share of -$7.78 in the same period. It has Quick Ratio of 0.18 while making debt-to-equity ratio of 0.00. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for ZVSA, volatility over the week remained 27.89% while standing at 19.98% over the month.
